{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:40:40Z","timestamp":1788018040771,"version":"build-2784847793"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109345","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T07:45:17Z","timestamp":1669275917000},"page":"109345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders"],"prefix":"10.1016","volume":"224","author":[{"given":"Briana K.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109345_bib1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41380-019-0597-8","article-title":"MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior","volume":"25","author":"Allen","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1523\/JNEUROSCI.3114-15.2016","article-title":"Previous ketamine produces an enduring blockade of neurochemical and behavioral effects of uncontrollable stress","volume":"36","author":"Amat","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.1976.01770100055005","article-title":"5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?","volume":"33","author":"Asberg","year":"1976","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.biopsych.2016.06.012","article-title":"Ketamine and imipramine reverse transcriptional signatures of susceptibility and induce resilience-specific gene expression profiles","volume":"81","author":"Bagot","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib6","first-page":"340","article-title":"Intranasal esketamine (Spravato(TM)) for use in treatment-resistant depression in conjunction with an oral antidepressant","volume":"44","author":"Bahr","year":"2019","journal-title":"P T"},{"key":"10.1016\/j.neuropharm.2022.109345_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.adolescence.2016.07.004","article-title":"The effectiveness of the Penn Resiliency Programme (PRP) and its adapted versions in reducing depression and anxiety and improving explanatory style: a systematic review and meta-analysis","volume":"52","author":"Bastounis","year":"2016","journal-title":"J. Adolesc."},{"key":"10.1016\/j.neuropharm.2022.109345_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cmi.12061","article-title":"Structural basis of innate immune recognition of viral RNA","volume":"15","author":"Berke","year":"2013","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109345_bib11","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2015.04.022","article-title":"Ketamine as a prophylactic against stress-induced depressive-like behavior","volume":"79","author":"Brachman","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.conb.2013.01.010","article-title":"Optogenetic interrogations of the neural circuits underlying addiction","volume":"23","author":"Britt","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2307\/2577823","article-title":"Social origins of depression: a study of psychiatric disorders in women","volume":"58","author":"Brown","year":"1979","journal-title":"Soc. Forces"},{"key":"10.1016\/j.neuropharm.2022.109345_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1037\/a0017671","article-title":"A meta-analytic review of the Penn Resiliency Program's effect on depressive symptoms","volume":"77","author":"Brunwasser","year":"2009","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113459","article-title":"Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: possible role of long-lasting pro-synaptogenic signaling pathway","volume":"334","author":"Camargo","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2021.09.057","article-title":"The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway","volume":"144","author":"Camargo","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110509","article-title":"Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment","volume":"115","author":"Camargo","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41386-020-0714-z","article-title":"Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopsych.2021.04.024","article-title":"Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior","volume":"90","author":"Chen","year":"2021","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41386-019-0540-3","article-title":"Prophylactic efficacy of 5-HT(4)R agonists against stress","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-022-01755-9","article-title":"Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis","author":"Codagnone","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.neuropharm.2022.109345_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.12104","article-title":"Ketamine and peripheral inflammation","volume":"19","author":"De Kock","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109345_bib149","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuron.2014.05.018","article-title":"Hippocampal memory traces are differentially modulated by experience, time, and adult neurogenesis","volume":"83","author":"Denny","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109345_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006842-200201000-00008","article-title":"Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis","volume":"64","author":"Dickens","year":"2002","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib28","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0025-18.2018","article-title":"Inhibition of a descending prefrontal circuit prevents ketamine-induced stress resilience in females","volume":"5","author":"Dolzani","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109345_bib29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/clpt.1984.235","article-title":"Ketamine kinetics in unmedicated and diazepam-premedicated subjects","volume":"36","author":"Domino","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109345_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)61033-8","article-title":"Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial","volume":"372","author":"Eggermont","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.109345_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19686","article-title":"Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic","volume":"3","author":"Ettman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2022.109345_bib35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ymthe.2021.11.006","article-title":"Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression","volume":"30","author":"Fan","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109345_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11011-010-9231-9","article-title":"A broad upregulation of cerebral chemokine genes by peripherally-generated inflammatory mediators","volume":"26","author":"Fil","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2022.109345_bib37","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/s41380-020-00953-7","article-title":"miR-323a regulates ERBB4 and is involved in depression","volume":"26","author":"Fiori","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib38","first-page":"466","article-title":"Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma","volume":"51","author":"Friebe","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2022.109345_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib40","article-title":"A new player in depression: MiRNAs as modulators of altered synaptic plasticity","volume":"23","author":"Gao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10802-005-9014-7","article-title":"Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program","volume":"34","author":"Gillham","year":"2006","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11414-013-9320-8","article-title":"Master resilience training and its relationship to individual well-being and stress buffering among army national guard soldiers","volume":"40","author":"Griffith","year":"2013","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10571-019-00684-6","article-title":"The missing link: how exosomes and miRNAs can help in bridging psychiatry and molecular biology in the context of depression, bipolar disorder and schizophrenia","volume":"39","author":"Gruzdev","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1041610220000903","article-title":"A systematic review of ketamine for the treatment of depression among older adults","volume":"33","author":"Gupta","year":"2021","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2016_28","article-title":"Inflammation-associated Co-morbidity between depression and cardiovascular disease","volume":"31","author":"Halaris","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109345_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12871-022-01588-7","article-title":"S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial","volume":"22","author":"Han","year":"2022","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib47","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/s41380-020-0685-9","article-title":"Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions","volume":"25","author":"Hare","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/mp.2015.211","article-title":"Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation","volume":"21","author":"Harraz","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1017\/S1092852915000929","article-title":"Comorbidity between neurological illness and psychiatric disorders","volume":"21","author":"Hesdorffer","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib51","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","article-title":"Group II metabotropic glutamate receptor blockade promotes stress resilience in mice","volume":"44","author":"Highland","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41398-021-01588-0","article-title":"miR-98-5p plays a critical role in depression and antidepressant effect of ketamine","volume":"11","author":"Huang","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00236","article-title":"Disconnectivity between dorsal raphe nucleus and posterior cingulate cortex in later life depression","volume":"9","author":"Ikuta","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib56","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","article-title":"Decreased expression of synapse-related genes and loss of synapses in major depressive disorder","volume":"18","author":"Kang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/1735-9066.157838","article-title":"Effect of stress inoculation training on the levels of stress, anxiety, and depression in cancer patients","volume":"20","author":"Kashani","year":"2015","journal-title":"Iran. J. Nurs. Midwifery Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-\u03b1 in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbi.2017.03.002","article-title":"NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings","volume":"64","author":"Kaufmann","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109345_bib148","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neubiorev.2014.11.009","article-title":"A computational theory of hippocampal function, and tests of the theory: new developments","volume":"48","author":"Kesner","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109345_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.neuropharm.2022.109345_bib61","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib62","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/M20-3738","article-title":"When the dust settles: preventing a mental health crisis in COVID-19 clinicians","volume":"173","author":"Kiser","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib63","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"Kohler","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11064-015-1746-3","article-title":"Cerebral response to peripheral challenge with a viral mimetic","volume":"41","author":"Konat","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13075-022-02799-6","article-title":"High risk of depression, anxiety, and an unfavorable complex comorbidity profile is associated with SLE: a nationwide patient-level study","volume":"24","author":"K\u00f3sa","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neuropharm.2022.109345_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jnr.21088","article-title":"Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation","volume":"85","author":"Krasowska-Zoladek","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071726","article-title":"Prophylactic ketamine treatment promotes resilience to chronic stress and accelerates recovery: correlation with changes in synaptic plasticity in the CA3 subregion of the Hippocampus","volume":"20","author":"Krzystyniak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2013.03.019","article-title":"Reward and aversion in a heterogeneous midbrain dopamine system","volume":"76 Pt B","author":"Lammel","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib69","first-page":"1720","volume":"vol. 12","author":"Lange","year":"2017"},{"key":"10.1016\/j.neuropharm.2022.109345_bib70","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1523\/JNEUROSCI.0577-11.2011","article-title":"Environmental enrichment confers stress resiliency to social defeat through an infralimbic cortex-dependent neuroanatomical pathway","volume":"31","author":"Lehmann","year":"2011","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109345_bib71","doi-asserted-by":"crossref","first-page":"R1870","DOI":"10.1152\/ajpregu.1997.273.6.R1870","article-title":"Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS","volume":"273","author":"Lenczowski","year":"1997","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib72","article-title":"Longitudinal Analysis of the impact of Master Resilience Training on self-reported resilience and psychological health data","author":"Lester","year":"2011","journal-title":"The Comprehensive Soldier Fitness program evaluation: Report 3"},{"key":"10.1016\/j.neuropharm.2022.109345_bib73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.126.3270.405.a","article-title":"Infantile experience and resistance to physiological stress","volume":"126","author":"Levine","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109345_bib74","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109345_bib75","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114396","article-title":"A single intravenous administration of a sub-anesthetic ketamine dose during the perioperative period of cesarean section for preventing postpartum depression: a meta-analysis","volume":"310","author":"Li","year":"2022","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109345_bib78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/archdischild-2020-319541","article-title":"Psychiatric comorbidity is common in dystonia and other movement disorders","volume":"106","author":"Lorentzos","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neuropharm.2022.109345_bib79","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.neuropharm.2022.109345_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.psychres.2019.03.026","article-title":"Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section","volume":"279","author":"Ma","year":"2019","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109250","article-title":"A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model","volume":"219","author":"Ma","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-022-02192-6","article-title":"A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-022-01803-6","article-title":"Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112238","article-title":"Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors","volume":"378","author":"Mastrodonato","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2018.02.011","article-title":"Ventral CA3 activation mediates prophylactic ketamine efficacy against stress-induced depressive-like behavior","author":"Mastrodonato","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib86","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ijnp\/pyac020","article-title":"Prophylactic (R,S)-Ketamine is effective against stress-induced behaviors in adolescent but not aged mice","volume":"25","author":"Mastrodonato","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.105.091199","article-title":"Ketamine produces lasting disruptions in encoding of sensory stimuli","volume":"316","author":"Maxwell","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109345_bib88","first-page":"S195","article-title":"The correlation between ketamine and posttraumatic stress disorder in burned service members","volume":"64","author":"McGhee","year":"2008","journal-title":"J. Trauma"},{"key":"10.1016\/j.neuropharm.2022.109345_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7205\/MILMED-D-13-00481","article-title":"The intraoperative administration of ketamine to burned U.S. service members does not increase the incidence of post-traumatic stress disorder","volume":"179","author":"McGhee","year":"2014","journal-title":"Mil. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib90","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41386-018-0043-7","article-title":"Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress","volume":"43","author":"McGowan","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2017.19","article-title":"Prophylactic ketamine attenuates learned fear","author":"McGowan","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib92","first-page":"2","article-title":"Promoting psychological resilience in the U.S. Military","volume":"1","author":"Meredith","year":"2011","journal-title":"Rand Health Q"},{"key":"10.1016\/j.neuropharm.2022.109345_bib93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/PDR.0b013e318212c196","article-title":"Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?","volume":"69","author":"Meyer","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109345_bib95","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/0033-295X.112.2.417","article-title":"Life stress, the \"kindling\" hypothesis, and the recurrence of depression: considerations from a life stress perspective","volume":"112","author":"Monroe","year":"2005","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109345_bib96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"5867","key":"10.1016\/j.neuropharm.2022.109345_bib147","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1151120","article-title":"Transgenic inhibition of synaptic transmission reveals role of CA3 output in hippocampal learning","volume":"319","author":"Nakashiba","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109345_bib97","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(98)01191-3","article-title":"\u0394FosB: a molecular mediator of long-term neural and behavioral plasticity1Published on the World Wide Web on 27 November 1998.1","volume":"835","author":"Nestler","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib99","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(05)74028-9","article-title":"Prophylactic antidepressant treatment before patients are admitted","volume":"355","author":"Niculescu","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.109345_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.581360","article-title":"Sex differences in the sustained effects of ketamine on resilience to chronic stress","volume":"14","author":"Okine","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib101","article-title":"GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour","author":"Pan","year":"2011","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.neuropharm.2022.109345_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2016.15111500","article-title":"Neurometabolic disorders: potentially treatable Abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"174","author":"Pan","year":"2017","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2021.05.002","article-title":"The resilient phenotype induced by prophylactic ketamine exposure during adolescence is mediated by the ventral tegmental area-nucleus accumbens pathway","volume":"90","author":"Parise","year":"2021","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib104","article-title":"Purine and pyrimidine metabolism: convergent evidence on chronic antidepressant treatment response in mice and humans","volume":"6","author":"Park","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109345_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110209","article-title":"Psychological comorbidity in gastrointestinal diseases: update on the brain-gut-microbiome axis","volume":"107","author":"Person","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib106","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-022-28190-2","article-title":"NAc-VTA circuit underlies emotional stress-induced anxiety-like behavior in the three-chamber vicarious social defeat stress mouse model","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109345_bib150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrn.2017.10","article-title":"Operation and plasticity of hippocampal CA3 circuits: implications for memory encoding","volume":"18","author":"Rebola","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109345_bib107","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1097\/01.aids.0000192087.64432.ae","article-title":"Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study","volume":"19","author":"Reichenberg","year":"2005","journal-title":"Aids"},{"key":"10.1016\/j.neuropharm.2022.109345_bib108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/a0021897","article-title":"Master resilience training in the U.S. Army","volume":"66","author":"Reivich","year":"2011","journal-title":"Am. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw028","article-title":"Inflammation models of depression in rodents: relevance to psychotropic drug discovery","volume":"19","author":"Remus","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1566-0702(00)00232-0","article-title":"Lipopolysaccharide transport from the peritoneal cavity to the blood: is it controlled by the vagus nerve?","volume":"85","author":"Romanovsky","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib111","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41398-022-02116-4","article-title":"The role of BDNF in mediating the prophylactic effects of (R,S)-ketamine on fear generalization and extinction","volume":"12","author":"Ryan","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109345_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/srep21322","article-title":"Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent manner","volume":"6","author":"Saland","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109345_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2021.02.020","article-title":"Intranasal esketamine: from origins to future implications in treatment-resistant depression","volume":"137","author":"Sanders","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib114","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ajem.2020.04.030","article-title":"Preserving mental health and resilience in frontline healthcare workers during COVID-19","volume":"38","author":"Santarone","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2009.01.004","article-title":"Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide","volume":"33","author":"Savitz","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109345_bib116","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/mp.2010.34","article-title":"Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress","volume":"15","author":"Schloesser","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib117","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1523\/JNEUROSCI.5352-12.2013","article-title":"Physical exercise prevents stress-induced activation of granule neurons and enhances local inhibitory mechanisms in the dentate gyrus","volume":"33","author":"Schoenfeld","year":"2013","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109345_bib118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/08039488809103238","article-title":"Prophylactic treatment of mood disorders","volume":"42","author":"Schou","year":"1988","journal-title":"Nord. Psykiatr. Tidsskr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12245-020-00299-5","article-title":"Physical and mental health impacts of COVID-19 on healthcare workers: a scoping review","volume":"13","author":"Shaukat","year":"2020","journal-title":"Int. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04993-7","article-title":"Dual action of ketamine confines addiction liability","volume":"608","author":"Simmler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109345_bib121","article-title":"Ketamine metabolites enantioselectively decrease intracellular D-serine concentrations in PC-12 cells","volume":"11","author":"Singh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109345_bib122","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0116-15.2016","article-title":"New hippocampal neurons mature rapidly in response to ketamine but are not required for its acute antidepressant effects on neophagia in rats","volume":"3","author":"Soumier","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109345_bib123","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jinf.2005.07.021","article-title":"The history of the smallpox vaccine","volume":"52","author":"Stewart","year":"2006","journal-title":"J. Infect."},{"key":"10.1016\/j.neuropharm.2022.109345_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100370","article-title":"Reactivating a positive feedback loop VTA-BLA-NAc circuit associated with positive experience ameliorates the attenuated reward sensitivity induced by chronic stress","volume":"15","author":"Sun","year":"2021","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2022.109345_bib125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib126","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/JCP.0000000000000090","article-title":"Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder","volume":"34","author":"Szymkowicz","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib127","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/jcb.26599","article-title":"MicroRNAs and exosomes in depression: potential diagnostic biomarkers","volume":"119","author":"Tavakolizadeh","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2022.109345_bib128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1742-2094-11-73","article-title":"Peripheral inflammation is associated with remote global gene expression changes in the brain","volume":"11","author":"Thomson","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109345_bib129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109345_bib130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nn.2551","article-title":"\u0394FosB in brain reward circuits mediates resilience to stress and antidepressant responses","volume":"13","author":"Vialou","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0164-4","article-title":"Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats","volume":"50","author":"Wan","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib132","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib133","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109345_bib134","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00404-017-4334-8","article-title":"Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial","volume":"295","author":"Xu","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.neuropharm.2022.109345_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03009734.2012.724118","article-title":"Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test","volume":"118","author":"Yang","year":"2013","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2022.109345_bib136","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-Ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib137","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12017-014-8312-z","article-title":"MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine","volume":"16","author":"Yang","year":"2014","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuropharm.2022.109345_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172876","article-title":"(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression","volume":"191","author":"Yokoyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109345_bib139","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109345_bib140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109345_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109345_bib142","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109345_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai7884","article-title":"Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine","volume":"9","author":"Zhang","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2022.109345_bib144","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109345_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113895","article-title":"Ketamine sex- and dose-dependently mitigates behavioral sequelae induced by a predator-based psychosocial stress model of post-traumatic stress disorder","volume":"428","author":"Zoladz","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109345_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111312","article-title":"The miRNome of Depression","volume":"22","author":"\u017burawek","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:22:58Z","timestamp":1758439378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082200404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":150,"alternative-id":["S002839082200404X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109345","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109345"}}